LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Thomas Silberg, president of Abraxis Pharmaceutical Products, the company’s hospital-based products division, will present a company overview at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 7, 2007 at 8:40 a.m. ET at the Grand Hyatt Hotel in New York City.
